CMPX Compass Therapeutics, Inc.
Nasdaq · SEC CIK 1738021 · EDGAR
- Bought, last 12 months
- $75.6K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 103 since 2021-11-08, latest 2026-04-30 16:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Anderman Jonathan | GC | $47.2K | — |
| Lerner Neil | CAO | $28.4K | — |
| Shin Barry | CFO | — | — |
| Schuetz Thomas J. | CEO, Dir | — | — |
Transactions 60
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-04-30 16:00 | 2026-04-29 | CMPX | Lerner Neil | CAO | P - Purchase | $1.89 | +15.0K | 397.5K | +4% | +$28.4K |
| A | 2026-04-30 16:00 | 2026-04-29 | CMPX | Anderman Jonathan | GC | P - Purchase | $1.89 | +25.0K | 196.0K | +15% | +$47.2K |
| 2026-04-29 17:11 | 2026-04-29 | CMPX | Anderman Jonathan | GC | A - Grant | $1.89 | +25.0K | 196.0K | +15% | +$47.2K | |
| 2026-04-29 16:58 | 2026-04-29 | CMPX | Lerner Neil | CAO | A - Grant | $1.89 | +15.0K | 397.5K | +4% | +$28.4K | |
| 2026-02-10 | 2026-02-08 | CMPX | Schuetz Thomas J. | CEO, Dir | F - Tax | $6.52 | -36.7K | 6.60M | -0.6% | -$239.2K | |
| 2026-01-12 | 2026-01-09 | CMPX | Schuetz Thomas J. | CEO, Dir | F - Tax | $5.35 | -46.8K | 6.64M | -0.7% | -$250.3K | |
| D | 2026-01-05 | 2026-01-02 | CMPX | Schuetz Thomas J. | CEO, Dir | A - Grant | $5.17 | +250.0K | 6.69M | +4% | +$1.29M |
| D | 2026-01-05 | 2026-01-02 | CMPX | Lerner Neil | CAO | A - Grant | $5.17 | +62.5K | 382.5K | +20% | +$323.1K |
| D | 2026-01-05 | 2026-01-02 | CMPX | Anderman Jonathan | GC | A - Grant | $5.17 | +150.0K | 171.0K | +714% | +$775.5K |
| D | 2026-01-05 | 2026-01-02 | CMPX | Shin Barry | CFO | A - Grant | $5.17 | +125.0K | 525.0K | +31% | +$646.2K |
| 2025-11-18 | 2025-11-16 | CMPX | Schuetz Thomas J. | CEO, Dir | F - Tax | $4.83 | -44.0K | 6.44M | -0.7% | -$212.6K | |
| 2025-05-27 | 2025-05-27 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.11 | +10.0K | 6.48M | +0.2% | +$21.1K | |
| I | 2025-04-11 | 2025-04-09 | CMPX | GORDON CARL L | Dir, 10% | S - Sale | $1.59 | -3.57M | 0 | -100% | -$5.68M |
| I | 2025-04-11 | 2025-04-09 | CMPX | OrbiMed Capital GP VI LLC | Dir, 10% | S - Sale | $1.59 | -3.57M | 0 | -100% | -$5.68M |
| 2025-04-08 | 2025-04-07 | CMPX | Anderman Jonathan | Gen Counsel, Corp. Sec | P - Purchase | $1.54 | +20.0K | 21.0K | +2,000% | +$30.8K | |
| 2025-04-08 | 2025-04-07 | CMPX | Lerner Neil | CAO | P - Purchase | $1.42 | +20.0K | 320.0K | +7% | +$28.4K | |
| 2025-02-11 | 2025-02-08 | CMPX | Schuetz Thomas J. | CEO, Dir | F - Tax | $3.50 | -41.7K | 6.47M | -0.6% | -$145.9K | |
| 2025-01-13 | 2025-01-09 | CMPX | Schuetz Thomas J. | CEO, Dir | F - Tax | $1.86 | -58.1K | 6.51M | -0.9% | -$108.0K | |
| D | 2024-12-10 | 2024-12-09 | CMPX | Shin Barry | CFO | A - Grant | $1.65 | +400.0K | 400.0K | New | +$660.0K |
| 2024-02-09 | 2024-02-08 | CMPX | Schuetz Thomas J. | Pres, Dir | F - Tax | $1.45 | -44.8K | 6.57M | -0.7% | -$64.9K | |
| 2024-02-09 | 2024-02-08 | CMPX | Bisker-Leib Vered | CEO, Dir | F - Tax | $1.45 | -49.2K | 3.12M | -2% | -$71.3K | |
| D | 2024-01-10 | 2024-01-09 | CMPX | Schuetz Thomas J. | Pres of R, D, Dir | A - Grant | $1.93 | +637.5K | 6.62M | +11% | +$1.23M |
| D | 2024-01-10 | 2024-01-09 | CMPX | Bisker-Leib Vered | CEO, Dir | A - Grant | $1.93 | +1.75M | 3.17M | +123% | +$3.38M |
| 2023-11-21 | 2023-11-17 | CMPX | Schuetz Thomas J. | CEO, Dir | F - Tax | $1.50 | -44.0K | 5.98M | -0.7% | -$66.0K | |
| 2023-11-21 | 2023-11-17 | CMPX | Bisker-Leib Vered | COO | F - Tax | $1.50 | -64.4K | 1.42M | -4% | -$96.6K | |
| 2023-03-10 | 2023-03-10 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.37 | +10.0K | 6.02M | +0.2% | +$33.7K | |
| 2023-02-27 | 2023-02-27 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.98 | +20.0K | 6.01M | +0.3% | +$79.6K | |
| 2023-02-15 | 2023-02-15 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.86 | +20.0K | 5.99M | +0.3% | +$77.2K | |
| D | 2023-02-09 | 2023-02-08 | CMPX | Bisker-Leib Vered | COO | A - Grant | $0.00 | +400.0K | 1.48M | +37% | $0 |
| D | 2023-02-09 | 2023-02-08 | CMPX | Schuetz Thomas J. | CEO, Dir | A - Grant | $0.00 | +500.0K | 5.97M | +9% | $0 |
| 2023-01-31 | 2023-01-31 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $4.05 | +20.0K | 5.47M | +0.4% | +$81.0K | |
| 2023-01-24 | 2023-01-24 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $4.19 | +20.0K | 5.45M | +0.4% | +$83.8K | |
| M | 2022-11-25 | 2022-11-22+ | CMPX | Bisker-Leib Vered | COO | S - Sale | $4.23 | -24.5K | 1.06M | -2% | -$103.7K |
| M | 2022-11-22 | 2022-11-18+ | CMPX | Bisker-Leib Vered | COO | S - Sale | $4.36 | -22.3K | 1.08M | -2% | -$97.0K |
| I | 2022-11-10 | 2022-11-08 | CMPX | GORDON CARL L | Dir, 10% | P - Purchase | $3.21 | +402.0K | 15.22M | +3% | +$1.29M |
| I | 2022-11-10 | 2022-11-08 | CMPX | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $3.21 | +402.0K | 15.22M | +3% | +$1.29M |
| 2022-09-28 | 2022-09-28 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.32 | +10.0K | 5.43M | +0.2% | +$23.2K | |
| 2022-09-27 | 2022-09-26 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.27 | +15.0K | 5.42M | +0.3% | +$34.0K | |
| 2022-09-08 | 2022-09-07 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.03 | +15.0K | 5.41M | +0.3% | +$45.5K | |
| 2022-09-01 | 2022-09-01 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.83 | +15.0K | 5.39M | +0.3% | +$42.5K | |
| 2022-08-17 | 2022-08-17 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.05 | +15.0K | 5.38M | +0.3% | +$45.8K | |
| 2022-08-10 | 2022-08-10 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.64 | +15.0K | 5.36M | +0.3% | +$39.6K | |
| 2022-08-02 | 2022-08-01 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.58 | +15.0K | 5.35M | +0.3% | +$38.7K | |
| 2022-06-21 | 2022-06-21 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.80 | +20.0K | 5.33M | +0.4% | +$56.0K | |
| 2022-06-17 | 2022-06-16 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.34 | +20.0K | 5.31M | +0.4% | +$46.8K | |
| 2022-06-13 | 2022-06-13 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.29 | +30.0K | 5.29M | +0.6% | +$68.7K | |
| 2022-06-07 | 2022-06-06 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.83 | +30.0K | 5.26M | +0.6% | +$84.9K | |
| 2022-06-01 | 2022-06-01 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.03 | +20.0K | 5.23M | +0.4% | +$60.6K | |
| 2022-05-26 | 2022-05-26 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $3.04 | +20.0K | 5.21M | +0.4% | +$60.8K | |
| 2022-05-24 | 2022-05-23 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.72 | +18.4K | 5.19M | +0.4% | +$49.9K | |
| 2022-05-17 | 2022-05-17 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $2.47 | +20.2K | 5.17M | +0.4% | +$49.9K | |
| MI | 2022-05-13 | 2022-05-11+ | CMPX | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $2.18 | +192.5K | 14.82M | +1% | +$420.5K |
| MI | 2022-05-13 | 2022-05-11+ | CMPX | GORDON CARL L | Dir, 10% | P - Purchase | $2.18 | +192.5K | 14.69M | +1% | +$420.5K |
| MI | 2022-05-10 | 2022-05-06+ | CMPX | GORDON CARL L | Dir, 10% | P - Purchase | $1.57 | +125.4K | 14.51M | +0.9% | +$197.3K |
| 2022-05-10 | 2022-05-10 | CMPX | Schuetz Thomas J. | CEO, Dir | P - Purchase | $1.80 | +27.8K | 5.15M | +0.5% | +$50.1K | |
| MI | 2022-05-10 | 2022-05-06+ | CMPX | OrbiMed Capital GP V LLC | Dir, 10% | P - Purchase | $1.57 | +125.4K | 14.63M | +0.9% | +$197.3K |
| 2021-11-18 | 2021-11-16 | CMPX | Bisker-Leib Vered | COO | A - Grant | $0.00 | +600.0K | 1.11M | +117% | $0 | |
| 2021-11-18 | 2021-11-16 | CMPX | Schuetz Thomas J. | CEO, Dir | A - Grant | $0.00 | +600.0K | 5.13M | +13% | $0 | |
| MI | 2021-11-08 | 2021-11-04 | CMPX | OrbiMed Genesis GP LLC | Dir, 10% | P - Purchase | $3.50 | +5.36M | 3.57M | New | +$18.75M |
| MI | 2021-11-08 | 2021-11-04 | CMPX | GORDON CARL L | Dir, 10% | P - Purchase | $3.50 | +5.36M | 3.57M | New | +$18.75M |